MWAM
BMY icon

Manhattan West Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Manhattan West Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,804
Closed -$264K – 123
2023
Q1 		$264K Buy
+3,804
New +$268K 0.11% 113

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Manhattan West Asset Management's BMY Position: Q2 2023 in Review

Manhattan West Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,804 shares — an estimated $264K sold.

Manhattan West Asset Management first reported a position in BMY in Q1 2023 and held it in 1 quarter. The position peaked at $264K in Q1 2023. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Manhattan West Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Manhattan West Asset Management sold 3,804 Bristol-Myers Squibb shares in Q2 2023, an estimated $264K.
  • Manhattan West Asset Management first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 1 quarter.
  • Manhattan West Asset Management's Bristol-Myers Squibb position peaked at $264K in Q1 2023.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Manhattan West Asset Management's 13F filing for Q2 2023, filed 1 Sep 2023.